From: Vaccine market and production capabilities in the Americas
| Product description | Part (%) |
|---|---|
| Medications conditioned for retail sale | 59% |
| Vaccines and antiserum | 26% |
| Pharmaceutical preparations and devices | 8% |
| Provitamins and vitamins natural or reproduced by synthesis | 3% |
| Natural or reproduced hormones by synthesis | 3% |
| Other | 1% |